Nath Bio-Genes (India) Limited (NATHBIOGEN) — Financial Results
Nath Bio-Genes (India) Limited announced its Q4 and FY26 earnings conference call scheduled for May 5, 2026 at 4:00 PM IST, hosted by Go India Advisors with key executives including CFO Amol Gupta and MD Satish Kagliwal, providing investors a platform to discuss financial results and outlook.
About Nath Bio-Genes (India) Limited (NATHBIOGEN)
Fast Moving Consumer Goods · Agricultural Food & other Products · Listed on NSE
📡 Get AI alerts when NATHBIOGEN files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track NATHBIOGEN — Free💡 Ask AI about this filing
📊 More NATHBIOGEN filings
- Financial Results — 26 June 2026 Nath Bio-Genes (India) Limited announced that its trading window will close on 1 July 2026 and remai...
- regulation 31 — 19 June 2026 Nath Bio-Genes (India) Limited filed its SEBI Regulation 31 disclosure for the year ended March 31, ...
- 🔴 Financial Results — 11 May 2026 Nath Bio-Genes reported FY26 revenue of **₹4,316 million**, up 19% YoY, with PAT at **₹384 million**...
- 🟡 Board Meeting — 4 May 2026 Nath Bio-Genes (India) Limited announced the outcome of its Board meeting on 4 May 2026, approving s...
- 🔴 Financial Results — 4 May 2026 Nath Bio-Genes reported FY26 revenue of **₹4,316 crores**, up 19% YoY, driven by cotton (+28% value ...
🔥 Also filed on 29 April 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when NATHBIOGEN files new disclosures
Track NATHBIOGEN filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track NATHBIOGEN — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research